Laura Cortesi

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results

Francesco Sardanelli, Franca Podo, G D'Agnolo et al. · Radiology · 2007 · 341 citations · Full text

Medicine, Oncology, Radiology +17

Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study)

Francesco Sardanelli, Franca Podo, Filippo Santoro et al. · Investigative Radiology · 2010 · 337 citations · Full text

Medicine, Oncology, Radiology +17

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

Andrea DeCensi, Matteo Puntoni, Aliana Guerrieri‐Gonzaga et al. · Journal of Clinical Oncology · 2019 · 216 citations · Full text

Medicine, Oncology, Pharmacotherapy +17